Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01622634 · ClinicalTrials.gov registry record · NA

Effect of a High-Protein Diet and/or High-Intensity Training on Metabolic Syndrome

A NA study, sponsored by University of Georgia.

Completed
Registry status
NA
Development phase
49
Enrollment target

NCT01622634: Completed NA study, sponsored by University of Georgia.

NCT01622634 is a NA study that has completed, run by University of Georgia. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01622634, a NA study, has completed, sponsored by University of Georgia.

COMPLETED
Registry status
NA
Development phase
49 participants
Enrollment target

Study Summary

The objective of this study is to determine the combined effects of a high-protein diet and high-intensity training on metabolic syndrome risk factors in women aged 30-65.

Primary Outcome

1. Post-Prandial Lipemia (and/or metabolic responses including insulin, glucose, triglycerides and free-fatty acids) to: a) a high fat meal challenge and b) a meal challenge similar to the higher protein or carbohydrate treatment arm. After an overnight fast and baseline blood draws, participants will consume a small meal and have their blood sampled every 30 minutes for 3 hours. 2. Biomarkers for Cardiovascular Disease and Diabetes Mellitus. Fasting blood samples for serum lipids, glucose, insu

Interventions

  • BEHAVIORAL Sprint Interval Exercise
  • OTHER Higher PRO Diet
  • OTHER Higher CARB Diet

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2012-02
Est. Completion 2013-03
Phase NA
University of Georgia

59 total trials

What the finished NCT01622634 record still lists

NCT01622634 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 3 interventions - of which Sprint Interval Exercise is the first listed.

NCT01622634 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01622634 about?

NCT01622634 is a clinical study titled "Effect of a High-Protein Diet and/or High-Intensity Training on Metabolic Syndrome". The objective of this study is to determine the combined effects of a high-protein diet and high-intensity training on metabolic syndrome risk factors in women aged 30-65.

What is the current status of trial NCT01622634?

This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2012-02. Estimated completion is 2013-03.

What interventions are being tested in trial NCT01622634?

The interventions under investigation include: Sprint Interval Exercise (BEHAVIORAL), Higher PRO Diet (OTHER), Higher CARB Diet (OTHER).

Who is sponsoring clinical trial NCT01622634?

This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01622634's enrollment target sits among peer trials

49 1379th of 2000 higher than 620 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02704858 · 49 participants · Phase 1

    Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

  • NCT03516708 · 49 participants · Phase 1

    Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

  • NCT03692429 · 49 participants · Phase 1

    alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

  • NCT04329494 · 49 participants · Phase 1

    PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01622634, the US trial registry maintained by the National Library of Medicine. NCT01622634 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.